The fields of obesity and type 2 diabetes (T2D) are rapidly evolving, and 2022 has seen a number of exciting advances that have the potential to dramatically improve patient health outcomes and quality of life.
Sign up for a free ASCEND account to continue reading.
ASCEND provides CME-accredited content designed to improve the care of people living with diabetes and obesity worldwide. Watch experts share their clinical insights, talk through case studies, address frequently asked questions, and much more!Sign up today
Already a member? Login